Skip to main content
Livermore
Livermore
ZHEN

E Fund Management Co., Ltd.

SEC CIK
0001842296
Latest filing
Aug 10, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of FOLD by E Fund Management Co., Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−40,461−100.0%Sold outHolders
Q1 202640,461$585.1K<0.1%–No prior filingHolders
Q3 2025––––Not filedHolders
Q2 202546,326$265.4K<0.1%+22,610+95.3%AddedHolders
Q1 202523,716$193.5K<0.1%+21+0.1%AddedHolders
Q4 202423,695$223.2K<0.1%−2,472−9.4%ReducedHolders
Q3 202426,167$279.5K<0.1%−1,567−5.7%ReducedHolders
Q2 202427,734$275.1K<0.1%−7,498−21.3%ReducedHolders
Q1 202435,232$415.0K<0.1%−7,316−17.2%ReducedHolders
Q4 202342,548$603.8K<0.1%+6,171+17.0%AddedHolders
Q3 202336,377$442.0K<0.1%+1,510+4.3%AddedHolders
Q2 202334,867$438.0K<0.1%+1,109+3.3%AddedHolders
Q1 202333,758$374.0K<0.1%−2,403−6.6%ReducedHolders
Q4 202236,161$442.0K<0.1%−5,551−13.3%ReducedHolders
Q3 202241,712$435.0K<0.1%−10,727−20.5%ReducedHolders
Q2 202252,439$563.0K0.1%+23,564+81.6%AddedHolders
Q1 202228,875$273.0K<0.1%+12,006+71.2%AddedHolders
Q4 202116,869$195.0K<0.1%+1,098+7.0%AddedHolders
Q3 202115,771$151.0K<0.1%–No prior filingHolders
Q2 2021––––Not filedHolders
Q1 202112,862$127.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.